ROSEN, A GLOBAL LAW FIRM, Urges Dentsply Sirona Inc. Investors To Secure Counsel Ahead Of Critical Deadline In Securities Class Action.

New York, New York–(Newsfile Corp. – December 29, 2024) – WHY: The Rosen Law Firm, a global investor rights law firm, reminds consumers of Dentsply Sirona Inc.’s common stock. (NASDAQ: XRAY) between February 28, 2022 and November 6, 2024, both dates inclusive (the “Class Period”), for the January 27, 2025 is the deadline for the plaintiff.

NOW: If you purchased Dentsply Sirona common stock during the Class Period you may be entitled to compensation without payment of any out-of-pocket payments or expenses through the contingency fee plan.

WHAT YOU NEED TO DO: To join a Dentsply Sirona class action, visit or call Phillip Kim, Esq. at 866-767-3653 or email case@rosenlegal.com for more information. A class action lawsuit has already been filed. If you wish to act as the lead plaintiff, you must remove the Court no later than January 27, 2025. The lead plaintiff is the organization representing the other members of the class directing the lawsuit.

WHY THE LAW WENT OUT: We encourage investors to select qualified advisors with a track record of success in leadership roles. Generally, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these companies are not responsible for the actions of the security department, but they are partners who refer customers or partners with law firms who prosecute cases. Be wise in choosing advice. The Rosen Law Firm represents investors worldwide, focusing its practice on securities class actions and shareholder exit litigation. The Rosen Law Firm won the largest securities class action settlement ever against a Chinese Company at the time. The Rosen Law Firm is ranked #1 by ISS Securities Class Action (WA:) Value services for securities class agreements in 2017. The company has been listed in the top 4 every year since 2013 and has returned hundreds of millions of dollars to investors. In 2019 alone the company secured more than 438 million from investors. In 2020, founding partner Laurence Rosen was named by Law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s lawyers are recognized by Lawdragon and Super Lawyers.

CASE DETAILS: According to the lawsuit, during the Class Period, the defendants made false and/or misleading statements and/or failed to disclose that: (1) Dentsply Sirona targeted low-income individuals who did not have access to good oral hygiene education, dentistry, or dental insurance, which often meant that patients signed up Byte, a direct-to-consumer (“DTC”) alignment solution, had some basic teething problems. ineligible for treatment; (2) pressure to increase Byte’s sales commissions caused sales staff to sell to restricted patients; (3) because of the above, Byte’s patient workflow did not provide sufficient assurance that the disputed patients did not enter treatment; (4) prior to and during the Class Period, reports of Byte’s patient injuries were coming in; (5) Dentsply Sirona knew that its Byte directors were causing serious patient harm for years but did little to investigate those harms or notify the US Food and Drug Administration (“FDA”); (6) Dentsply Sirona had no plans to notify the FDA of this injury, which Dentsply Sirona is required to do within 30 days of learning of the problem; (7) the FDA had found a sharp increase in reports of serious injuries to Byte patients; (8) as a result of the above, Dentsply Sirona significantly exceeded the value of Byte’s goodwill; and (9) as a result of the foregoing, defendants’ positive statements about Dentsply Sirona’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis at all relevant times. When true information enters the market, the lawsuit claims that investors suffered damages.

To join a Dentsply Sirona class action, visit or call Phillip Kim, Esq. toll free at 866-767-3653 or email case@rosenlegal.com for information about the class action.

No Class Guaranteed. Until the class is certified, you are not represented by an attorney unless you retain it. You can choose the advice of your choice. You can also remain a member of the absent class and do nothing for now. The investor’s ability to participate in any potential future returns is not dependent on performance as the lead claimant.

Follow us for updates on LinkedIn: on Twitter: or on Facebook (NASDAQ:):

Advocate advertising. Previous results do not guarantee the same result.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/235173